BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6956807)

  • 21. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission.
    Cortes JE; Kantarjian HM; O'Brien S; Giles F; Keating MJ; Freireich EJ; Estey EH
    Cancer; 1999 Apr; 85(7):1506-13. PubMed ID: 10193940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of circulating immune complexes with cytogenetic abnormalities but not with prognosis in acute nonlymphocytic leukemia.
    Crane MM; Rossen RD; McCredie KB; Trujillo JM
    Cancer Res; 1984 Jul; 44(7):3125-31. PubMed ID: 6609770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors.
    Mehta J; Powles R; Singhal S; Horton C; Tait D; Milan S; Meller S; Pinkerton CR; Treleaven J
    Bone Marrow Transplant; 1995 Oct; 16(4):499-506. PubMed ID: 8528164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognosis of children with acute myelocytic leukemia after first relapse].
    Creutzig U; Ritter J; Boos J; Zimmermann M; Bender-Götze C; Stahnke K
    Klin Padiatr; 1998; 210(4):207-11. PubMed ID: 9743954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement.
    Martín G; Barragán E; Bolufer P; Chillón C; García-Sanz R; Gómez T; Brunet S; González M; Sanz MA
    Haematologica; 2000 Jul; 85(7):699-703. PubMed ID: 10897121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of CD56 antigen expression in acute myeloid leukemia.
    Di Bona E; Sartori R; Zambello R; Guercini N; Madeo D; Rodeghiero F
    Haematologica; 2002 Mar; 87(3):250-6. PubMed ID: 11869936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Circulating immune complexes in human leukemias].
    Carpentier NA; Zubler RH; Lange GT; Lambert PH; Miescher PA
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1363-4. PubMed ID: 1070156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsed from first complete remission.
    Ferrara F; Morabito F; Latagliata R; Martino B; Annunziata M; Oliva E; Schiavone EM; Pollio F; Palmieri S; Gianfaldoni G; Leoni F
    Haematologica; 2001 Aug; 86(8):814-20. PubMed ID: 11522537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. hTERT mRNA levels by real-time RT-PCR in acute myelogenous leukemia.
    Huh HJ; Huh JW; Yoo ES; Seong CM; Lee M; Hong KS; Chung WS
    Am J Hematol; 2005 Aug; 79(4):267-73. PubMed ID: 16044449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of prognostic factors in patients with refractory acute myeloid leukemia].
    Zhang Q; Feng R; Liu QF; Liu XL; Xu B; Zheng WY; Meng FY; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):934-6. PubMed ID: 13129725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
    Wong R; Shahjahan M; Wang X; Thall PF; De Lima M; Khouri I; Gajewski J; Alamo J; Couriel D; Andersson BS; Donato M; Hosing C; Komanduri K; Anderlini P; Molldrem J; Ueno NT; Estey E; Ippoliti C; Champlin R; Giralt S
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):108-14. PubMed ID: 15682071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of acute myeloid leukemias in the adult in relapse].
    Thomas X; Le QH
    Bull Cancer; 2002 Sep; 89(9):795-807. PubMed ID: 12368132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia.
    Schiffman K; Clift R; Appelbaum FR; Sanders J; Bensinger W; Petersen FB; Rowley S; Hill R; Martin P; Storb R
    Bone Marrow Transplant; 1993 Mar; 11(3):227-32. PubMed ID: 8467288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of treatment in immune thrombocytopenia.
    Jacobs P; Wood L; Dent DM
    Q J Med; 1986 Feb; 58(226):153-65. PubMed ID: 3714968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
    Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
    Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
    Krauter J; Wagner K; Schäfer I; Marschalek R; Meyer C; Heil G; Schaich M; Ehninger G; Niederwieser D; Krahl R; Büchner T; Sauerland C; Schlegelberger B; Döhner K; Döhner H; Schlenk RF; Ganser A
    J Clin Oncol; 2009 Jun; 27(18):3000-6. PubMed ID: 19380453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of glutathione transferase pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia.
    Tidefelt U; Elmhorn-Rosenborg A; Paul C; Hao XY; Mannervik B; Eriksson LC
    Cancer Res; 1992 Jun; 52(12):3281-5. PubMed ID: 1596886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.